Abrogation of TNFα Production During Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12

PLoS ONE - United States
doi 10.1371/journal.pone.0090116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)


Related search